Rank | Gene Set | Z-score |
---|---|---|
1 | drug catabolic process (GO:0042737) | 9.61886705 |
2 | epoxygenase P450 pathway (GO:0019373) | 8.65352007 |
3 | omega-hydroxylase P450 pathway (GO:0097267) | 8.41924253 |
4 | regulation of fibrinolysis (GO:0051917) | 8.33195476 |
5 | negative regulation of fibrinolysis (GO:0051918) | 8.13244437 |
6 | glyoxylate metabolic process (GO:0046487) | 8.02332819 |
7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.96638599 |
8 | L-phenylalanine catabolic process (GO:0006559) | 7.96638599 |
9 | complement activation, alternative pathway (GO:0006957) | 7.77568056 |
10 | regulation of protein activation cascade (GO:2000257) | 7.36423588 |
11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.32644378 |
12 | L-phenylalanine metabolic process (GO:0006558) | 7.32644378 |
13 | urea metabolic process (GO:0019627) | 7.08873341 |
14 | regulation of complement activation (GO:0030449) | 6.85003015 |
15 | fibrinolysis (GO:0042730) | 6.72470070 |
16 | drug metabolic process (GO:0017144) | 6.45450694 |
17 | nitrogen cycle metabolic process (GO:0071941) | 6.44816200 |
18 | protein carboxylation (GO:0018214) | 6.37747836 |
19 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.37747836 |
20 | oxidative demethylation (GO:0070989) | 6.25422296 |
21 | bile acid biosynthetic process (GO:0006699) | 6.23798534 |
22 | ethanol oxidation (GO:0006069) | 6.16605467 |
23 | * cellular glucuronidation (GO:0052695) | 6.08238200 |
24 | urea cycle (GO:0000050) | 5.94047815 |
25 | blood coagulation, intrinsic pathway (GO:0007597) | 5.88468671 |
26 | aromatic amino acid family catabolic process (GO:0009074) | 5.84611418 |
27 | * uronic acid metabolic process (GO:0006063) | 5.77450301 |
28 | * glucuronate metabolic process (GO:0019585) | 5.77450301 |
29 | serine family amino acid catabolic process (GO:0009071) | 5.72977595 |
30 | regulation of triglyceride catabolic process (GO:0010896) | 5.71637239 |
31 | phenylpropanoid metabolic process (GO:0009698) | 5.67437646 |
32 | negative regulation of cholesterol transport (GO:0032375) | 5.62224106 |
33 | negative regulation of sterol transport (GO:0032372) | 5.62224106 |
34 | bile acid metabolic process (GO:0008206) | 5.58456436 |
35 | regulation of plasminogen activation (GO:0010755) | 5.23613713 |
36 | glycine metabolic process (GO:0006544) | 5.18087447 |
37 | bile acid and bile salt transport (GO:0015721) | 5.10141730 |
38 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.99032756 |
39 | ethanol metabolic process (GO:0006067) | 4.97714433 |
40 | negative regulation of hemostasis (GO:1900047) | 4.92033274 |
41 | negative regulation of blood coagulation (GO:0030195) | 4.92033274 |
42 | protein activation cascade (GO:0072376) | 4.86027950 |
43 | S-adenosylmethionine metabolic process (GO:0046500) | 4.79644732 |
44 | acylglycerol homeostasis (GO:0055090) | 4.69171193 |
45 | triglyceride homeostasis (GO:0070328) | 4.69171193 |
46 | tyrosine metabolic process (GO:0006570) | 4.67335172 |
47 | alkaloid metabolic process (GO:0009820) | 4.64303461 |
48 | amino-acid betaine metabolic process (GO:0006577) | 4.60464881 |
49 | complement activation (GO:0006956) | 4.55030307 |
50 | acute-phase response (GO:0006953) | 4.53653347 |
51 | negative regulation of coagulation (GO:0050819) | 4.47105133 |
52 | complement activation, classical pathway (GO:0006958) | 4.46972128 |
53 | negative regulation of wound healing (GO:0061045) | 4.43825839 |
54 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.40860928 |
55 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.40860928 |
56 | imidazole-containing compound metabolic process (GO:0052803) | 4.38704303 |
57 | phospholipid efflux (GO:0033700) | 4.36196239 |
58 | regulation of humoral immune response (GO:0002920) | 4.34257781 |
59 | negative regulation of protein activation cascade (GO:2000258) | 4.31749396 |
60 | flavonoid metabolic process (GO:0009812) | 4.25827126 |
61 | hormone catabolic process (GO:0042447) | 4.22973955 |
62 | positive regulation of blood coagulation (GO:0030194) | 4.16709401 |
63 | positive regulation of hemostasis (GO:1900048) | 4.16709401 |
64 | doxorubicin metabolic process (GO:0044598) | 4.13647896 |
65 | daunorubicin metabolic process (GO:0044597) | 4.13647896 |
66 | polyketide metabolic process (GO:0030638) | 4.13647896 |
67 | serine family amino acid metabolic process (GO:0009069) | 4.12655757 |
68 | plasma lipoprotein particle remodeling (GO:0034369) | 4.10043477 |
69 | protein-lipid complex remodeling (GO:0034368) | 4.10043477 |
70 | macromolecular complex remodeling (GO:0034367) | 4.10043477 |
71 | arginine metabolic process (GO:0006525) | 4.08339389 |
72 | opsonization (GO:0008228) | 4.01260663 |
73 | negative regulation of lipase activity (GO:0060192) | 3.97075900 |
74 | tryptophan catabolic process (GO:0006569) | 3.96142813 |
75 | indole-containing compound catabolic process (GO:0042436) | 3.96142813 |
76 | indolalkylamine catabolic process (GO:0046218) | 3.96142813 |
77 | cholesterol efflux (GO:0033344) | 3.94830660 |
78 | heme transport (GO:0015886) | 3.94566573 |
79 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.93248424 |
80 | high-density lipoprotein particle remodeling (GO:0034375) | 3.89842694 |
81 | cytolysis (GO:0019835) | 3.89228527 |
82 | alpha-amino acid catabolic process (GO:1901606) | 3.88896499 |
83 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.87417659 |
84 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.87417659 |
85 | intestinal cholesterol absorption (GO:0030299) | 3.86356765 |
86 | positive regulation of coagulation (GO:0050820) | 3.84918247 |
87 | glutamate metabolic process (GO:0006536) | 3.82670437 |
88 | aromatic amino acid family metabolic process (GO:0009072) | 3.80070539 |
89 | regulation of cholesterol esterification (GO:0010872) | 3.75488637 |
90 | response to mercury ion (GO:0046689) | 3.75234087 |
91 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.71770022 |
92 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.67115167 |
93 | steroid catabolic process (GO:0006706) | 3.65180157 |
94 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.63219523 |
95 | * xenobiotic metabolic process (GO:0006805) | 3.59276185 |
96 | negative regulation of complement activation (GO:0045916) | 3.55230818 |
97 | serine family amino acid biosynthetic process (GO:0009070) | 3.51534390 |
98 | reverse cholesterol transport (GO:0043691) | 3.49331296 |
99 | cellular ketone body metabolic process (GO:0046950) | 3.48299730 |
100 | exogenous drug catabolic process (GO:0042738) | 10.2522183 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.13834167 |
2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.99084738 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.97121511 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.73863615 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.35167664 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.85456739 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.66774391 |
8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.40055396 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.01842247 |
10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.19159677 |
11 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.11109462 |
12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.10342052 |
13 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.02516659 |
14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.01560149 |
15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.4644890 |
16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.80357895 |
17 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.55831771 |
18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55409518 |
19 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.54679715 |
20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.26878553 |
21 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.16048741 |
22 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.15886850 |
23 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13933879 |
24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.10160102 |
25 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.07688962 |
26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.06532219 |
27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.05651836 |
28 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.02458989 |
29 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96930714 |
30 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.92262246 |
31 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.89910535 |
32 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.89423759 |
33 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.86150448 |
34 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.84917422 |
35 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.84576781 |
36 | CBP_21632823_ChIP-Seq_H3396_Human | 0.81843710 |
37 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.79487723 |
38 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.78795214 |
39 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.78327812 |
40 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.78026347 |
41 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.77544213 |
42 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.76535094 |
43 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.75406300 |
44 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.75198537 |
45 | AR_20517297_ChIP-Seq_VCAP_Human | 0.75044878 |
46 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.74676708 |
47 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.74292359 |
48 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.73745260 |
49 | GATA1_22025678_ChIP-Seq_K562_Human | 0.73173182 |
50 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.73072016 |
51 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.71722938 |
52 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.71629023 |
53 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.70079378 |
54 | NFYA_21822215_ChIP-Seq_K562_Human | 0.69867897 |
55 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.67916479 |
56 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.67623806 |
57 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.67031047 |
58 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.65995775 |
59 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.64968032 |
60 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.64925351 |
61 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.63970599 |
62 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.62611123 |
63 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.62534969 |
64 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.62252215 |
65 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.59464742 |
66 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.59252090 |
67 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.58728653 |
68 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.58211938 |
69 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.57688606 |
70 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.57388544 |
71 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.56127063 |
72 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.54633211 |
73 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.54428244 |
74 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.54245593 |
75 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.53379593 |
76 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.53235302 |
77 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.52578606 |
78 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.52435433 |
79 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.52174112 |
80 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.51976242 |
81 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.51701363 |
82 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.51089232 |
83 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.51049672 |
84 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.51042708 |
85 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.50962206 |
86 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.50781512 |
87 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.50754996 |
88 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.50605551 |
89 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.50190706 |
90 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.50168500 |
91 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.50091596 |
92 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.50091596 |
93 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.48388709 |
94 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.47393918 |
95 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.47175565 |
96 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.47094117 |
97 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.46852524 |
98 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.46210052 |
99 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.46165118 |
100 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.46084640 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 9.93712601 |
2 | MP0005085_abnormal_gallbladder_physiolo | 6.47229666 |
3 | MP0005360_urolithiasis | 6.06678371 |
4 | MP0005365_abnormal_bile_salt | 6.01203020 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.72000303 |
6 | MP0003195_calcinosis | 4.96577236 |
7 | MP0002138_abnormal_hepatobiliary_system | 4.50207869 |
8 | MP0003252_abnormal_bile_duct | 4.24544523 |
9 | MP0003868_abnormal_feces_composition | 3.62299493 |
10 | MP0001666_abnormal_nutrient_absorption | 3.39320398 |
11 | MP0009697_abnormal_copulation | 2.90890212 |
12 | MP0010329_abnormal_lipoprotein_level | 2.72134270 |
13 | MP0003806_abnormal_nucleotide_metabolis | 2.34215895 |
14 | MP0009840_abnormal_foam_cell | 2.31951516 |
15 | MP0005332_abnormal_amino_acid | 2.31611839 |
16 | MP0003191_abnormal_cellular_cholesterol | 2.16064399 |
17 | MP0002876_abnormal_thyroid_physiology | 1.95726081 |
18 | MP0000609_abnormal_liver_physiology | 1.86058279 |
19 | MP0002118_abnormal_lipid_homeostasis | 1.67503875 |
20 | MP0001764_abnormal_homeostasis | 1.59736631 |
21 | MP0010368_abnormal_lymphatic_system | 1.48175316 |
22 | MP0004019_abnormal_vitamin_homeostasis | 1.33548622 |
23 | MP0009053_abnormal_anal_canal | 1.18715564 |
24 | MP0005319_abnormal_enzyme/_coenzyme | 1.17202736 |
25 | MP0005408_hypopigmentation | 1.14692112 |
26 | MP0005670_abnormal_white_adipose | 1.09350526 |
27 | MP0001661_extended_life_span | 1.03736683 |
28 | MP0000598_abnormal_liver_morphology | 1.03621855 |
29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.03349484 |
30 | MP0002132_abnormal_respiratory_system | 0.97998211 |
31 | MP0009643_abnormal_urine_homeostasis | 0.96244016 |
32 | MP0003656_abnormal_erythrocyte_physiolo | 0.95033750 |
33 | MP0005451_abnormal_body_composition | 0.93219696 |
34 | MP0003186_abnormal_redox_activity | 0.87393512 |
35 | MP0009764_decreased_sensitivity_to | 0.86928192 |
36 | MP0001915_intracranial_hemorrhage | 0.86044545 |
37 | MP0009763_increased_sensitivity_to | 0.85549421 |
38 | MP0000604_amyloidosis | 0.83935141 |
39 | MP0005187_abnormal_penis_morphology | 0.82570662 |
40 | MP0009642_abnormal_blood_homeostasis | 0.81888881 |
41 | MP0005376_homeostasis/metabolism_phenot | 0.79659454 |
42 | MP0008469_abnormal_protein_level | 0.79118959 |
43 | MP0002971_abnormal_brown_adipose | 0.78859560 |
44 | MP0005395_other_phenotype | 0.71002480 |
45 | MP0005636_abnormal_mineral_homeostasis | 0.70410346 |
46 | MP0003879_abnormal_hair_cell | 0.68596695 |
47 | MP0003011_delayed_dark_adaptation | 0.68268217 |
48 | MP0002282_abnormal_trachea_morphology | 0.66097846 |
49 | MP0005535_abnormal_body_temperature | 0.64874887 |
50 | MP0005464_abnormal_platelet_physiology | 0.64032516 |
51 | MP0003690_abnormal_glial_cell | 0.62599412 |
52 | MP0008872_abnormal_physiological_respon | 0.62481751 |
53 | MP0002168_other_aberrant_phenotype | 0.61036046 |
54 | MP0003638_abnormal_response/metabolism_ | 0.59207483 |
55 | MP0008874_decreased_physiological_sensi | 0.58406169 |
56 | MP0005266_abnormal_metabolism | 0.56925992 |
57 | MP0002249_abnormal_larynx_morphology | 0.54856512 |
58 | MP0002078_abnormal_glucose_homeostasis | 0.53427895 |
59 | MP0005023_abnormal_wound_healing | 0.51407447 |
60 | MP0005334_abnormal_fat_pad | 0.48828576 |
61 | MP0009785_altered_susceptibility_to | 0.45392766 |
62 | MP0006036_abnormal_mitochondrial_physio | 0.44995776 |
63 | MP0005058_abnormal_lysosome_morphology | 0.41475955 |
64 | MP0000249_abnormal_blood_vessel | 0.40779219 |
65 | MP0009765_abnormal_xenobiotic_induced | 0.39874196 |
66 | MP0004130_abnormal_muscle_cell | 0.39484864 |
67 | MP0005166_decreased_susceptibility_to | 0.38295807 |
68 | MP0005164_abnormal_response_to | 0.35981379 |
69 | MP0003075_altered_response_to | 0.33915949 |
70 | MP0004883_abnormal_blood_vessel | 0.33339077 |
71 | MP0000467_abnormal_esophagus_morphology | 0.32503565 |
72 | MP0005448_abnormal_energy_balance | 0.31755009 |
73 | MP0002136_abnormal_kidney_physiology | 0.31603094 |
74 | MP0004782_abnormal_surfactant_physiolog | 0.29636681 |
75 | MP0003718_maternal_effect | 0.29537975 |
76 | MP0008873_increased_physiological_sensi | 0.27502913 |
77 | MP0002332_abnormal_exercise_endurance | 0.26262475 |
78 | MP0003329_amyloid_beta_deposits | 0.25140100 |
79 | MP0001851_eye_inflammation | 0.24955094 |
80 | MP0005647_abnormal_sex_gland | 0.24798674 |
81 | MP0003705_abnormal_hypodermis_morpholog | 0.24573145 |
82 | MP0003959_abnormal_lean_body | 0.24552276 |
83 | MP0005197_abnormal_uvea_morphology | 0.23267364 |
84 | MP0001845_abnormal_inflammatory_respons | 0.23240407 |
85 | MP0003953_abnormal_hormone_level | 0.23234649 |
86 | MP0009115_abnormal_fat_cell | 0.22799956 |
87 | MP0005220_abnormal_exocrine_pancreas | 0.20346128 |
88 | MP0002090_abnormal_vision | 0.20004414 |
89 | MP0002928_abnormal_bile_duct | 0.19510748 |
90 | MP0002970_abnormal_white_adipose | 0.18941217 |
91 | MP0005083_abnormal_biliary_tract | 0.18925602 |
92 | MP0001756_abnormal_urination | 0.18556293 |
93 | MP0005084_abnormal_gallbladder_morpholo | 0.18272906 |
94 | MP0000920_abnormal_myelination | 0.16394123 |
95 | MP0000566_synostosis | 0.16221469 |
96 | MP0005666_abnormal_adipose_tissue | 0.15903494 |
97 | MP0002089_abnormal_postnatal_growth/wei | 0.15894355 |
98 | MP0002128_abnormal_blood_circulation | 0.15576198 |
99 | MP0003632_abnormal_nervous_system | 0.14984784 |
100 | MP0001881_abnormal_mammary_gland | 0.14567602 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Complement deficiency (HP:0004431) | 9.02533914 |
2 | Prolonged partial thromboplastin time (HP:0003645) | 8.93254136 |
3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 8.40165301 |
4 | Hypobetalipoproteinemia (HP:0003563) | 8.04803550 |
5 | Abnormality of complement system (HP:0005339) | 7.33905184 |
6 | Conjugated hyperbilirubinemia (HP:0002908) | 6.95105649 |
7 | Systemic lupus erythematosus (HP:0002725) | 6.12414981 |
8 | Joint hemorrhage (HP:0005261) | 6.07915265 |
9 | Hyperlipoproteinemia (HP:0010980) | 5.92066324 |
10 | Intrahepatic cholestasis (HP:0001406) | 5.56848607 |
11 | Glomerulonephritis (HP:0000099) | 5.01170511 |
12 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.97573974 |
13 | Xanthomatosis (HP:0000991) | 4.82623692 |
14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.70999886 |
15 | Hypolipoproteinemia (HP:0010981) | 4.61668565 |
16 | Spontaneous abortion (HP:0005268) | 4.24284694 |
17 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.20741361 |
18 | Abnormality of the intrinsic pathway (HP:0010989) | 3.99290769 |
19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.96386574 |
20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.79162768 |
21 | Nephritis (HP:0000123) | 3.76297946 |
22 | Fat malabsorption (HP:0002630) | 3.68528270 |
23 | Hypoalphalipoproteinemia (HP:0003233) | 3.34100291 |
24 | Hyperglycinemia (HP:0002154) | 3.32104192 |
25 | Hyperammonemia (HP:0001987) | 3.31196822 |
26 | Abnormality of methionine metabolism (HP:0010901) | 3.21660466 |
27 | Generalized aminoaciduria (HP:0002909) | 3.12253611 |
28 | Gingival bleeding (HP:0000225) | 3.03779988 |
29 | Rickets (HP:0002748) | 2.99758260 |
30 | Steatorrhea (HP:0002570) | 2.95825798 |
31 | Vascular calcification (HP:0004934) | 2.90596879 |
32 | Delayed CNS myelination (HP:0002188) | 2.90382776 |
33 | Mitral stenosis (HP:0001718) | 2.89157148 |
34 | Hemorrhage of the eye (HP:0011885) | 2.86985028 |
35 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.84236487 |
36 | Abnormality of glycine metabolism (HP:0010895) | 2.84236487 |
37 | Hypercholesterolemia (HP:0003124) | 2.82150044 |
38 | Abnormality of nucleobase metabolism (HP:0010932) | 2.71946355 |
39 | Hyperbilirubinemia (HP:0002904) | 2.68029827 |
40 | Osteomalacia (HP:0002749) | 2.67918164 |
41 | Reduced antithrombin III activity (HP:0001976) | 2.67715297 |
42 | Abnormality of serum amino acid levels (HP:0003112) | 2.65651029 |
43 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.59426480 |
44 | Hyperglycinuria (HP:0003108) | 2.57836230 |
45 | Cardiovascular calcification (HP:0011915) | 2.57763738 |
46 | Epidermoid cyst (HP:0200040) | 2.55186542 |
47 | Thrombophlebitis (HP:0004418) | 2.50614926 |
48 | Purpura (HP:0000979) | 2.49168435 |
49 | Hepatocellular carcinoma (HP:0001402) | 2.40648762 |
50 | Pulmonary embolism (HP:0002204) | 2.38901762 |
51 | Neonatal hypoglycemia (HP:0001998) | 2.37850128 |
52 | Menorrhagia (HP:0000132) | 2.34888276 |
53 | Fair hair (HP:0002286) | 2.32883389 |
54 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.30294247 |
55 | Cholelithiasis (HP:0001081) | 2.19278139 |
56 | Cholecystitis (HP:0001082) | 2.18730322 |
57 | Abnormal gallbladder physiology (HP:0012438) | 2.18730322 |
58 | Metabolic acidosis (HP:0001942) | 2.17982243 |
59 | Hyperphosphaturia (HP:0003109) | 2.13705882 |
60 | Abnormality of vitamin metabolism (HP:0100508) | 2.13093305 |
61 | Abnormality of the Achilles tendon (HP:0005109) | 2.12461440 |
62 | Arthropathy (HP:0003040) | 2.11940338 |
63 | Abnormal gallbladder morphology (HP:0012437) | 2.07316835 |
64 | Elevated alkaline phosphatase (HP:0003155) | 2.04265640 |
65 | Irritability (HP:0000737) | 2.03428254 |
66 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 10.6807575 |
67 | Deep venous thrombosis (HP:0002625) | 10.2063009 |
68 | Glycosuria (HP:0003076) | 1.99196827 |
69 | Abnormality of urine glucose concentration (HP:0011016) | 1.99196827 |
70 | Myocardial infarction (HP:0001658) | 1.96820749 |
71 | Hypochromic microcytic anemia (HP:0004840) | 1.94909599 |
72 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.90373327 |
73 | Bifid scrotum (HP:0000048) | 1.89349433 |
74 | Ketosis (HP:0001946) | 1.87559012 |
75 | Joint swelling (HP:0001386) | 1.85640998 |
76 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.84768763 |
77 | Increased mean platelet volume (HP:0011877) | 1.82250992 |
78 | Increased serum ferritin (HP:0003281) | 1.81498652 |
79 | Hypophosphatemic rickets (HP:0004912) | 1.81010731 |
80 | Abnormality of iron homeostasis (HP:0011031) | 1.80624396 |
81 | Gangrene (HP:0100758) | 1.75998185 |
82 | Hydroxyprolinuria (HP:0003080) | 1.73722902 |
83 | Abnormality of proline metabolism (HP:0010907) | 1.73722902 |
84 | Atrioventricular block (HP:0001678) | 1.72229895 |
85 | Abnormal urine phosphate concentration (HP:0012599) | 1.71980341 |
86 | Poikilocytosis (HP:0004447) | 1.71520461 |
87 | Abnormality of purine metabolism (HP:0004352) | 1.68533696 |
88 | Bile duct proliferation (HP:0001408) | 1.66865388 |
89 | Abnormal biliary tract physiology (HP:0012439) | 1.66865388 |
90 | Abnormal platelet volume (HP:0011876) | 1.64837402 |
91 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.63501286 |
92 | Epistaxis (HP:0000421) | 1.63286890 |
93 | Cerebral palsy (HP:0100021) | 1.62328340 |
94 | Lethargy (HP:0001254) | 1.60905171 |
95 | Generalized hypopigmentation of hair (HP:0011358) | 1.60487463 |
96 | Impaired platelet aggregation (HP:0003540) | 1.55855680 |
97 | Abnormal platelet function (HP:0011869) | 1.55855680 |
98 | Alkalosis (HP:0001948) | 1.55533646 |
99 | Abnormality of the gallbladder (HP:0005264) | 1.52728012 |
100 | Skin nodule (HP:0200036) | 1.51850473 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 5.51001804 |
2 | PIK3CG | 3.78219419 |
3 | FGFR4 | 3.62225211 |
4 | RIPK1 | 3.58539664 |
5 | TRIB3 | 2.77780631 |
6 | TYK2 | 2.68543624 |
7 | SIK1 | 2.49652958 |
8 | BCKDK | 2.41949944 |
9 | PRKACG | 2.29940576 |
10 | PRPF4B | 2.26590111 |
11 | PIK3CA | 2.22469000 |
12 | MAP3K3 | 1.99260005 |
13 | EPHA3 | 1.95421265 |
14 | MST1R | 1.87008484 |
15 | MAP3K12 | 1.82351076 |
16 | MAP2K4 | 1.81072338 |
17 | TBK1 | 1.80092134 |
18 | NTRK3 | 1.74762670 |
19 | IRAK3 | 1.73743351 |
20 | ABL2 | 1.71245672 |
21 | PRKAA2 | 1.69548728 |
22 | MAPK11 | 1.62335796 |
23 | NEK9 | 1.52399162 |
24 | PRKCG | 1.51456009 |
25 | MYLK | 1.46150106 |
26 | FGFR3 | 1.37402248 |
27 | IGF1R | 1.36361482 |
28 | TAOK3 | 1.34313426 |
29 | JAK1 | 1.32889818 |
30 | PDPK1 | 1.25858315 |
31 | MAP3K2 | 1.13627432 |
32 | PINK1 | 1.12209900 |
33 | EPHA4 | 1.09485768 |
34 | TNK2 | 1.09211819 |
35 | NLK | 1.06713319 |
36 | ERBB2 | 1.05276905 |
37 | PRKCZ | 1.03213460 |
38 | PRKG1 | 0.97892260 |
39 | JAK2 | 0.97559765 |
40 | MAP3K1 | 0.97497051 |
41 | SCYL2 | 0.93705366 |
42 | TAOK2 | 0.91731151 |
43 | EPHB1 | 0.91514732 |
44 | FER | 0.90521221 |
45 | MAP3K11 | 0.85944485 |
46 | PRKACA | 0.84854178 |
47 | PDK1 | 0.82676444 |
48 | CAMKK2 | 0.78584290 |
49 | CDK6 | 0.78162151 |
50 | PKN2 | 0.77813666 |
51 | PRKAA1 | 0.76944504 |
52 | ZAP70 | 0.74888630 |
53 | RET | 0.72865014 |
54 | CSF1R | 0.72637542 |
55 | ERBB4 | 0.71951820 |
56 | MAP3K6 | 0.69688631 |
57 | ARAF | 0.69613190 |
58 | MAP2K3 | 0.68654511 |
59 | CSNK1D | 0.67364684 |
60 | PRKCB | 0.66883599 |
61 | MAP3K5 | 0.64268571 |
62 | KSR2 | 0.63272388 |
63 | PRKCA | 0.63021529 |
64 | PDK2 | 0.62898903 |
65 | ICK | 0.62160628 |
66 | STK38 | 0.60746904 |
67 | PTK6 | 0.59457945 |
68 | MET | 0.57920898 |
69 | RPS6KA3 | 0.55725171 |
70 | MAPK4 | 0.55379509 |
71 | KDR | 0.54775865 |
72 | CAMK2G | 0.54684818 |
73 | STK16 | 0.54382765 |
74 | MAPK7 | 0.53983606 |
75 | INSRR | 0.53548935 |
76 | DYRK1B | 0.53071408 |
77 | MAPKAPK3 | 0.52649943 |
78 | MAPK12 | 0.52565511 |
79 | TGFBR2 | 0.52361850 |
80 | SGK1 | 0.52195424 |
81 | GSK3A | 0.50905879 |
82 | SRC | 0.46106165 |
83 | TIE1 | 0.45186434 |
84 | PRKACB | 0.44306043 |
85 | CSNK1E | 0.40579130 |
86 | EIF2AK1 | 0.39941483 |
87 | CAMKK1 | 0.39134981 |
88 | SGK3 | 0.38346682 |
89 | MAP3K13 | 0.38167743 |
90 | PIM2 | 0.37230115 |
91 | CSNK2A1 | 0.36525200 |
92 | CDK4 | 0.36420850 |
93 | WNK3 | 0.35759343 |
94 | MAP2K2 | 0.34405752 |
95 | MTOR | 0.34249301 |
96 | DAPK2 | 0.33251677 |
97 | CAMK1D | 0.32773197 |
98 | IKBKE | 0.31576385 |
99 | CSNK1A1 | 0.31217695 |
100 | CSNK2A2 | 0.31163609 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.69788777 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.24283965 |
3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.13866004 |
4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.74346035 |
5 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.38714834 |
6 | * Retinol metabolism_Homo sapiens_hsa00830 | 3.36968939 |
7 | * Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.30059203 |
8 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.89578138 |
9 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.89139076 |
10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.74757134 |
11 | * Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.62890525 |
12 | * Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.55432989 |
13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.53341410 |
14 | * Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.52904095 |
15 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.47528170 |
16 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.34457938 |
17 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.23474841 |
18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.17703960 |
19 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.05687669 |
20 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.89825874 |
21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.87771927 |
22 | Bile secretion_Homo sapiens_hsa04976 | 1.87623852 |
23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.83145742 |
24 | * Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.61713525 |
25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.51792457 |
26 | * Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.41893523 |
27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.41558270 |
28 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.38783442 |
29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.37586798 |
30 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.37360326 |
31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.35716754 |
32 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.34167448 |
33 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.32873681 |
34 | Peroxisome_Homo sapiens_hsa04146 | 1.32146985 |
35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.24648674 |
36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.18700779 |
37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.15581616 |
38 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.15004262 |
39 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13187747 |
40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.07468994 |
41 | Prion diseases_Homo sapiens_hsa05020 | 1.05940168 |
42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.96761084 |
43 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.94740199 |
44 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93786784 |
45 | Carbon metabolism_Homo sapiens_hsa01200 | 0.87522495 |
46 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.84096665 |
47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.81355307 |
48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.78552376 |
49 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.77078860 |
50 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76551427 |
51 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.75940614 |
52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75361249 |
53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.75055640 |
54 | ABC transporters_Homo sapiens_hsa02010 | 0.75042568 |
55 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.57979899 |
56 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.53212334 |
57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.52410057 |
58 | Lysine degradation_Homo sapiens_hsa00310 | 0.49257522 |
59 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.42272011 |
60 | Pertussis_Homo sapiens_hsa05133 | 0.29181957 |
61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.27173771 |
62 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26001072 |
63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.25691366 |
64 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.25338737 |
65 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23721664 |
66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.23606861 |
67 | Insulin resistance_Homo sapiens_hsa04931 | 0.19940894 |
68 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.12623908 |
69 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10887620 |
70 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.10855772 |
71 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.07843995 |
72 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.07253565 |
73 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.06749804 |
74 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.06092623 |
75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.05839420 |
76 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.03798047 |
77 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.03669286 |
78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.01908504 |
79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.00977316 |
80 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2767432 |
81 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.2743844 |
82 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2633945 |
83 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2568918 |
84 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2544508 |
85 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.2411449 |
86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2368492 |
87 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.2143716 |
88 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.2005467 |
89 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1747960 |
90 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1662108 |
91 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1649631 |
92 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1107432 |
93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1058753 |
94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.1035043 |
95 | Amoebiasis_Homo sapiens_hsa05146 | -0.0528880 |
96 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | -0.0490012 |
97 | Mineral absorption_Homo sapiens_hsa04978 | -0.0448154 |
98 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0222518 |
99 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0027969 |
100 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0018705 |